eye treatment biosimilar
Scope
Date
~
-
Bio & Pharma
Medipost acquires Canada’s OmniaBio for CDMO business
Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...
May 31, 2022 (Gmt+09:00)
-
Carbon neutrality
SK E&S, Australia’s Santos eye joint carbon capture, hydrogen projects
SK E&S Co., the natural gas business unit of South Korea’s SK Group, and Australia’s leading energy company Santos Ltd. are seeking ...
May 26, 2022 (Gmt+09:00)
-
ASK 2022
Infrastructure shines amid rising inflation, Korean LPs say
Major institutional investors in South Korea have a largely positive outlook on infrastructure amid the macroeconomic risks, such as inflation and...
May 25, 2022 (Gmt+09:00)
-
ASK 2022
Teachers' Pension eyes direct lending, PE with low leverage
Teachers’ Pension (TP) of South Korea will increase exposure to its overseas alternative assets, its Chief Investment Officer Lee Kyu-hong sai...
May 19, 2022 (Gmt+09:00)
-
Metaverse
LG Uplus eyes metaverse niches for office workers, kids
South Korea’s LG Uplus Corp. will target specific groups of customers such as office workers and preschoolers for its metaverse platforms, set...
May 18, 2022 (Gmt+09:00)
-
Electronics
Volkswagen partner SoluM eyes top spot in global ESL market
SoluM Co., a South Korean mid-sized electronic component maker, is eyeing record performance this year, thanks to orders from Volkswagen AG and Elon...
May 17, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
SK On bolsters M&A team with new executive hires
SK On Co., an electric vehicle battery maker of SK Innovation Co., is bolstering its M&A team by hiring M&A experts from a leading law firm ...
May 17, 2022 (Gmt+09:00)
language -
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion to sell biosimilar products via its own channel in Europe
South Korea's biopharmaceutical company Celltrion Inc. plans to sell all of its biosimilar products through its own sales channels in Europe to impr...
May 11, 2022 (Gmt+09:00)
-
Korean startups
Fabless startup FADU eyes unicorn status with $157 mn funding
FADU Technology, a fabless startup that develops architecture for solid-state drive (SSD) controllers and storage products, is seeking to raise 200 ...
May 06, 2022 (Gmt+09:00)
-
Korean food
Nongshim eyes top spot in global instant noodle market
South Korea’s No. 1 noodle maker Nongshim Co. is aiming for top place in the world’s instant noodle market, looking to beat the current ...
May 03, 2022 (Gmt+09:00)
language -
IPOs
LG CNS eyes 2023 IPO to pave way for Macquarie's exit
South Korea's LG CNS Co., 35% owned by Macquarie Group, sent requests for proposals to brokerage companies on Monday as it is looking to go public n...
May 03, 2022 (Gmt+09:00)
-
Korean stock market
Foreign ownership of Korean shares hits lowest level since 2010
Foreign investors’ holding rate in South Korea’s main bourse Kospi has plunged to the lowest level since 2010. The investors have dispos...
Apr 26, 2022 (Gmt+09:00)
-
Corporate governance
Carlyle visits Hyundai Glovis seeking measures to boost value
The Carlyle Group, a US private equity giant, visited South Korea’s Hyundai Glovis Co. last week to discuss steps to boost the value of the Hy...
Apr 25, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Musinsa seeks to buy Japan-focused rival fashion platform
South Korea's top online fashion platform Musinsa is in the last stages of talks to acquire a domestic rival that caters primarily to Japanese shopp...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
IPOs
Two SK Group arms unveil lower-than-expected IPO guidance
SK Shieldus Co. and One Store Co., two units of South Korea's SK Square Co., submitted their initial public offering applications on Thursday to rai...
Apr 01, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
SK Hynix considers joint acquisition of UK chip designer Arm
South Korea's SK Hynix Inc. is considering forming a consortium with other strategic investors to buy Arm Ltd., a British semiconductor design compa...
Mar 30, 2022 (Gmt+09:00)
-
Electronics
OLED materials makers set to shine as Samsung, Sony unveil new TVs
South Korea’s major OLED materials makers are becoming the market darlings with decent gains in their share prices, as global TV manufacturers...
Mar 21, 2022 (Gmt+09:00)
-
RFPs
SK Ecoplant eyes H2 2023 Kospi listing
SK Ecoplant Co., South Korea's largest waste management company, said on Monday it has sent a request for proposal to major brokerage companies at h...
Mar 21, 2022 (Gmt+09:00)
-
Korean food
Nongshim aims for top instant noodle spot in the US
Nongshim Co., South Korea’s leading instant noodle maker is aiming for the top noodle spot in the US. The Korean food company will begin ope...
Mar 18, 2022 (Gmt+09:00)
-
Retail
Korea’s fashion OEM firms eye record sales
South Korea’s clothing original equipment manufacturers (OEM) are set to see a supercycle or a sustained period of expansion driven by robust ...
Mar 16, 2022 (Gmt+09:00)
-
Shipping & Shipbuilding
Hyundai eyes LNG ship-to-floating storage unit conversion market
The ongoing war in Ukraine and tougher emission standards are creating a new market for shipbuilders: converting aged liquefied natural gas (LNG) ca...
Mar 15, 2022 (Gmt+09:00)
-
Pharmaceuticals
Samsung Bioepis to double biosimilars, may resume Nasdaq listing plans
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, plans to double the number of its biosimilar products on sale to 10 by 2025 and acce...
Feb 24, 2022 (Gmt+09:00)
-
IPOs
Korean battery sector to heat up IPO market again
South Korea’s battery industry is expected to heat up the initial public offering market later this year as battery materials and equipment ma...
Feb 23, 2022 (Gmt+09:00)
-
Chief Executives
AI translation service Iyuno SDI chair expects continued surge in demand
“As demand for over-the-top (OTT) services grows, so will the bid for companies that provide translated subtitles in multiple languages,&rdq...
Feb 21, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
SK Ecoplant buys e-waste recycling firm for $1 bn
South Korea's SK Ecoplant Co. has acquired Singapore-based electronic waste (e-waste) disposal and recycling company TES Envirocorp Pte. Ltd for $1 ...
Feb 21, 2022 (Gmt+09:00)
language -
Pharmaceuticals
Samsung Bioepis posts $1.26 billion in global biosimilar sales
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said on Friday that sales of its five biosimilar products in global markets, excludi...
Feb 18, 2022 (Gmt+09:00)
Latest News
- 1 Coupang bids for Korean luxury market dominance with Farfetch
- 2 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 3 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 4 Korea to allow non-profits to buy bad consumer loans
- 5 LG to drive future growth in emerging markets with battery prowess